Financials

  • Market Capitalization 217.78 M
  • Employee 34
  • Founded 2004
  • CEO Christopher U. Missling Ph.D.
  • Website www.anavex.com
  • Headquarter New York, United States
  • FIGI BBG000C9K8K4
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-16.48
Fiyat/satışlar oranı
151.51

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3577
KROS
Keros Therapeutics, Inc. - common stock
10.88 USD-1.98%-2.77%+5.12%-27.95%215.34 M USD
3580
BCYC
Bicycle Therapeutics plc - American Depositary Shares
4.33 USD-0.46%-1.59%+2.36%-46.74%218.12 M USD
3584
CGEN
Compugen Ltd. - Ordinary Shares
2.26 USD-1.74%-3.83%+11.33%+40.37%213.69 M USD
3589
NBP
NovaBridge Biosciences - American Depositary Shares
1.83 USD-1.61%-9.41%+23.65%-59.42%211.15 M USD

Haberler